-
Je něco špatně v tomto záznamu ?
Locomotion in young rats with induced brain cellular edema - effects of recombinant human erythropoietin
D. Maresova, P. Kozler, E. Miletínová, T. Zima, J. Pokorny,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články
- MeSH
- chování zvířat účinky léků MeSH
- edém mozku patofyziologie MeSH
- erythropoetin farmakologie MeSH
- intoxikace vodou patofyziologie MeSH
- krysa rodu rattus MeSH
- lokomoce účinky léků MeSH
- neuroprotektivní látky farmakologie MeSH
- pohybová aktivita účinky léků MeSH
- potkani Wistar MeSH
- rekombinantní proteiny farmakologie MeSH
- věkové faktory MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: Effect of recombinant human erythropoietin (rhEPO) on spontaneous motor activity was tested in young rats after intraperitoneal (i.p.) administration of rhEPO, followed by induction of cellular brain edema (CE). Induced changes in the spontaneous horizontal locomotor activity was studied by open field test (OFT). METHODS: CE was induced by water intoxication (WI) using standard method of fractional hyperhydration accompanied with desmopressin administration. Using the accepted method of OFT average time spent in locomotion (s) was determined. 48 young rats at the age of 25, and 35 days were divided into three groups - controls, rats after WI (OFT followed after 44 hours), and rats administered with rhEPO prior to application WI (OFT after 48 hours). RESULTS: In 35-day-old rats rhEPO administration increased the spontaneous locomotor activity, previously decreased by cellular edema. In 25-day-old rats, rhEPO administration prior to the induced CE, decreased spontaneous locomotor activity. CONCLUSION: Presented results demonstrate the neuroprotective capacity of rhEPO, manifested by elimination of the suppressive influence of CE on the locomotion in 35-day-old rats. In 25-day-old rats the neuroprotective effect was not present. These results confirmed that the 10 day interval in the development may represent a different stage of brain maturation in the relation to the neuroprotective effect of rhEPO.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012060
- 003
- CZ-PrNML
- 005
- 20190405112111.0
- 007
- ta
- 008
- 190405s2018 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)30531705
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Maresova, Dana $u Institute of Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 245 10
- $a Locomotion in young rats with induced brain cellular edema - effects of recombinant human erythropoietin / $c D. Maresova, P. Kozler, E. Miletínová, T. Zima, J. Pokorny,
- 520 9_
- $a OBJECTIVES: Effect of recombinant human erythropoietin (rhEPO) on spontaneous motor activity was tested in young rats after intraperitoneal (i.p.) administration of rhEPO, followed by induction of cellular brain edema (CE). Induced changes in the spontaneous horizontal locomotor activity was studied by open field test (OFT). METHODS: CE was induced by water intoxication (WI) using standard method of fractional hyperhydration accompanied with desmopressin administration. Using the accepted method of OFT average time spent in locomotion (s) was determined. 48 young rats at the age of 25, and 35 days were divided into three groups - controls, rats after WI (OFT followed after 44 hours), and rats administered with rhEPO prior to application WI (OFT after 48 hours). RESULTS: In 35-day-old rats rhEPO administration increased the spontaneous locomotor activity, previously decreased by cellular edema. In 25-day-old rats, rhEPO administration prior to the induced CE, decreased spontaneous locomotor activity. CONCLUSION: Presented results demonstrate the neuroprotective capacity of rhEPO, manifested by elimination of the suppressive influence of CE on the locomotion in 35-day-old rats. In 25-day-old rats the neuroprotective effect was not present. These results confirmed that the 10 day interval in the development may represent a different stage of brain maturation in the relation to the neuroprotective effect of rhEPO.
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a chování zvířat $x účinky léků $7 D001522
- 650 _2
- $a edém mozku $x patofyziologie $7 D001929
- 650 _2
- $a erythropoetin $x farmakologie $7 D004921
- 650 _2
- $a lokomoce $x účinky léků $7 D008124
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pohybová aktivita $x účinky léků $7 D009043
- 650 _2
- $a neuroprotektivní látky $x farmakologie $7 D018696
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a rekombinantní proteiny $x farmakologie $7 D011994
- 650 _2
- $a intoxikace vodou $x patofyziologie $7 D014869
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kozler, Petr $u Institute of Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Miletínová, Eva $u National Institute of Mental Health, Czech Republic.
- 700 1_
- $a Zima, Tomas $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Pokorny, Jaroslav $u Institute of Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 39, č. 4 (2018), s. 310-314
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30531705 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190405112120 $b ABA008
- 999 __
- $a ok $b bmc $g 1391370 $s 1050365
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 39 $c 4 $d 310-314 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20190405